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Effects of lactate-buffered and lactate-free dialysate in CAVHD failure as part of their multiple organ failure syndrome
patients with and without liver dysfunction. in intensive care settings [1]. A range of different modal-
Background. Continuous modalities of renal replacement ities is available that rely solely on convective or ondeplete patients of bicarbonate, which is traditionally replaced
diffusive solute clearance or on combinations of the two.indirectly by lactate in dialysate or replacement fluids. We have
They all involve trading off low efficiency against thecompared a new lactate-free dialysate (unbuffered dialysate
with separate bicarbonate replacement of dialytic bicarbonate ability to correct fluid and electrolyte imbalances by
loss) with standard lactate-buffered dialysate in terms of acid- small incremental changes over extended treatment
base control, lactate accumulation, and hemodynamic stability
times. Both hemofiltration and dialysis against non–in patients undergoing continuous renal replacement therapy
bicarbonate-buffered solutions will clear bicarbonatein an intensive care unit.
Methods. A nonrandomized crossover cohort study involv- (HCO23 ) from the patients’ blood at rates between 1 and
ing 54 patients with multi-organ failure (of whom 19 had signifi- 2 L/hour. This means that irrespective of the potential
cant hepatic dysfunction) was performed. All patients completed benefits and disadvantages of correcting systemic acido-24-hour continuous hemodiafiltration against both lactate-buf-
sis in these patients by the administration of sodiumfered and lactate-free dialysate. Arterial pH, blood gases, bicar-
bonate, and lactate, venous sodium, blood pressure, and inotrope bicarbonate (NaHCO3) [2], they have an obligate re-
requirements were measured before and at six hourly intervals quirement for buffer replacement either through filtra-
during the first 24 hours of dialysis against each dialysate. tion replacement fluids or from dialysate. This require-Results. Lactate-free dialysate provided more rapid control
ment is especially important in the large proportion ofof acidosis than lactate buffered with less total administration
the patients with systemic acidosis as part of their multi-of buffer than that given during the lactate-buffered period
(total mmol bicarbonate vs. total mmol lactate 1 bicarbonate). ple organ failure syndrome. By definition, they will have
Lactate accumulation was slight in both periods, but was higher exhausted their fixed buffering capacity so that plasma
during lactate-buffered continuous venovenous hemodiafiltra-
HCO23 is their predominant remaining buffer [2]. Sodiumtion (CVVHD). The mean arterial pressure rose during lactate-
lactate has traditionally been used as the source of thisfree dialysis with decreased inotrope doses and fell during
lactate-buffered dialysis with increased inotrope requirement. buffer replacement, with titration of one proton per mol-
Results in patients with liver dysfunction were not significantly ecule of lactate used as substrate during gluconeogenesis
different from those without it.
or by oxidation in the liver or muscles, allowing theConclusions. Over the time scale of 24 hours, lactate derived
general assumption that lactate is “metabolized to bicar-from continuous dialysis circuits is efficiently cleared from the
blood of most patients with multi-organ failure, but with less bonate” on an equimolar basis [3].
effect on systemic acidosis than is produced by equivalent In patients with impaired liver function and failure of
amounts of bicarbonate.
skeletal muscle lactate metabolism caused by regional
hypoperfusion, the capacity to metabolize the lactate
delivered during renal replacement may become satu-Continuous renal replacement therapies (CRRTs) are
rated, with consequent lactate accumulation [4]. Whilewidely used for critically ill patients with acute renal
such hyperlactemia should not be equated with lactic
acidosis, it does imply that buffer is being removed dur-
Key words: continuous renal replacement therapy, acid-base balance,
ing filtration or dialysis without effective replacement.systemic acidosis, multi-organ failure, diffusive solute clearance, fluid
and electrolyte balance. To address this possibility, especially in patients with
acute liver dysfunction, we have developed a lactate-freeReceived for publication April 21, 1999
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distally in the renal replacement circuit or through access tate-buffered dialysate solution used was the standard
Baxter “Monosol” solution (Baxter, McGraw Park, IL,to a central vein separate from the filtration/dialysis ac-
cess. The dialysate is hyponatremic with respect to blood USA). The lactate-free dialysate solution was prepared
by Baxter (Table 1). CRRT circuits were anticoagulated(total Na1 concentration 115 mmol/L) to take account
of the Na1 administered in the bicarbonate infusion. The with heparin and/or prostacyclin or were run without
anticoagulation, depending on the patient’s clinical situa-NaHCO3 is administered at 25 mmol/h for each liter of
blood clearance of HCO23 (either by filtration or dialysis) tion.
so that patients are (indirectly) equilibrated to an HCO23
Exclusion of patients from analysisconcentration of 25 mmol/L and a Na1 concentration of
140 mmol/L. Patients who died (N 5 7) or who had CRRT stopped
because of recovery of renal function (N 5 5) beforeDuring the first three years after this solution was
introduced, we dialyzed more than 150 patients with this fulfilling the criteria of dialysis for 24 hours against both
dialysate solutions within 72 hours of starting CRRTsystem, and report here the findings on 54 patients who
received continuous hemodiafiltration with both lactate- were not included in the main analysis, but were analyzed
separately.buffered and lactate-free dialysate during their first 72
hours of continuous renal replacement therapy.
Parameters analyzed
Arterial pH, pO2, pCO2, and HCO23 were measuredMETHODS
on a Corning 178 blood gas analyzer (Chiron Diagnostics
Patients and CRRT modalities Halstead, Essex, UK). Venous L-lactate was measured
using a YSI Stat Plus lactate analyzer (YSI Inc., YellowAll patients who received continuous modality renal
replacement on the Royal Free Hospital Intensive Care Springs, OH, USA). Serum Na1, blood pressure, and
inotrope dosage were retrieved from intensive care unitUnit between May 1995 and May 1997 were identified
from the renal unit’s prospectively updated database of (ICU) clinical records for time points prior to the start
of CRRT with each dialysate solution and at six hourlyclinical activity. The hospital is a tertiary referral unit that
provides intensive care support to a university teaching intervals after the initiation of each treatment modality.
APACHE II scores at admission to ICU and worsthospital with active liver, kidney, and bone marrow trans-
plant programs. Analysis ran from the time when the APACHE II score within the first 24 hours of admission
were recorded in accordance with our standard ICUlactate-free dialysate was introduced to the time when the
modality of renal replacement used was changed from protocols.
In a subgroup of 20 patients, net bicarbonate and lac-hemodiafiltration to hemofiltration as a result of the in-
troduction of new CRRT technology. Patients who had tate balance across the CRRT circuit was assessed by
measurement of bicarbonate and lactate levels in bloodcompleted at least 24 hours of dialysis against both dialy-
sate solutions within 72 hours of the initiation of CRRT and dialysate compartments one hour after the initiation
of CRRT with each dialysate solution (Table 2). Thiswere included in the analysis. All patients were treated
with pumped hemodiafiltration, using either femoral showed that with the high blood flow relative to dialysate
flow in these circuits, small solute concentrations in thedual lumen catheters (venovenous) or ankle or wrist
arteriovenous shunts as vascular access. The CRRT cir- dialysate effluent were equal or close to that in incoming
blood.cuits were composed of Gambro AK10 machines (Gam-
bro AB, Lund, Sweden) with hollow-fiber polyacryloni- Inotropic support during each period was assessed as
either increased (commencement of inotropes or .10%trile 1.0 m2 surface area hemofilters (Hospal, Lyon,
France). Dialysate inflow and dialysate/ultrafiltrate out- increase in dosage during the 24-hour period), unchanged,
or decreased (cessation of inotropes or .10% dose re-flow was controlled by volume-limited pumps (Imed,
Abingdon, UK). All patients were dialyzed against 1.5 duction). Twenty-two of the patients required inotropic
support during either period of CRRT, with 21 receivingL/hour of dialysate through the continuous hemodiafil-
tration circuit, with blood flow rates of between 150 and norepinephrine, 7 epinephrine, 4 angiotensin II, and 3
dobutamine, alone or in combination.200 mL/min. Dialysate flow was countercurrent to blood
flow. Net ultrafiltration rates did not differ significantly
Calculation of total buffer administrationbetween the lactate-buffered and lactate-free periods.
The mean hourly ultrafiltration during lactate-buffered During CRRT against lactate-free dialysate, there is
net removal of bicarbonate from the blood compartmentversus lactate-free dialysis was 53 mL (95% CI, 43 to
64) versus 49 mL (95% CI, 39 to 58). The mean hourly and replacement of HCO23 via the HCO23 infusion. Dur-
ing CRRT against lactate-buffered dialysate, there is netfiltration in patients who received lactate-buffered versus
lactate-free dialysis first was 53 mL (95% CI, 43 to 62) removal of HCO23 from the blood with a net gain of
lactate from the dialysate (Table 2). In either situation,versus 51 mL (95% CI, 41 to 61), respectively. The lac-
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Table 1. Constitution of dialysate solutions
Lactate-free dialysate
Lactate-buffered Lactate-free plus 25 mmol of 8.4%
dialysate dialysate NaHCO3 per liter of dialysate
Lactate mmol/L 30 0 0
HCO23 mmol/L 0 0 24.4
Na1 mmol/L 140 110 131.7
Cl2 mmol/L 115 115 112.1
Ca11 mmol/L 1.75 1.75 1.71
Mg11 mmol/L 0.75 0.75 0.73
Ionic concentrations of lactate-buffered and lactate-free dialysate solutions used, and equivalent net ion concentration of lactate-free dialysate used with the
administration of 25 mmol of 8.4% NaHCO3 given per liter of lactate-free dialysate in the CVVHD cycle (assuming 100% equilibration of dialysate Na1 and
HCO23 to the blood compartment).
Table 2. Solute equilibration across the CRRT circuit
Equilibration
Pre-filter Pre-filter Post-filter Post-filter of dialysate to
blood dialysate blood dialysate blood %
Lactate-buffered dialysate
[Na1] mmol/L 137.2 140 138.1 137.9 100.5
[HCO23 ] mmol/L 17.82 0.0 14.44 17.46 98.0
[Lactate] mmol/L 1.86 30.0 1.99 2.08 111.8
Lactate-free dialysate
[Na1] mmol/L 136.8 110 136.4 135.6 99.1
[HCO23 ] mmol/L 22.58 0.0 18.88 21.26 94.2
[Lactate] mmol/L 2.23 0.0 1.06 2.21 99.1
Sodium, bicarbonate, and lactate equilibration across the CRRT circuit, with a blood pump speed of 200 mL/min and dialysate flow of 1.5 L/hour (25 mL/min)
in ten patients. Pre- and post-filter blood samples, and post-filter dialysate samples were taken one hour after the initiation of each system of CRRT. The degree of
equilibration is expressed as: 100 3 1 2 1pre-filter blood 2 post-filter dialysatepre-filter blood 2.
there may be buffer removal during net ultrafiltration. sate did not differ significantly from those who were
treated in the reverse order in terms of their Apache IIThe most important determinant of [H1] control in these
patients will be their ability to maintain adequate re- scores, their degree of acidosis, arterial blood gasses,
arterial bicarbonate, plasma sodium, or mean arterialgional perfusion of tissue beds. However, changes in
acid/base status will be affected by the amount of buffer pressure (MAP). Blood lactate prior to CRRT was sig-
nificantly higher in the patients who received lactate-administered, either through the CRRT circuit or sepa-
rately. The total buffer administered during CRRT with free dialysate first [mean lactate 2.31 (95% CI, 1.77 to
2.86) vs. 1.31 (95% CI, 1.02 to 1.60), P 5 0.02].lactate-free dialysate is easily determined as the total
HCO23 administered either as part of the CRRT prescrip-
Statistical analysistion or independently of it. During CRRT against lac-
tate-buffered dialysate, we extrapolated from the lactate Parametric variables including the physiological pa-
rameters ([H1], blood gases, blood Na1, and blood lac-flux information derived from a subgroup of our patients
to calculate the net administration of lactate during the tate) were analyzed by Student’s t-test, with 95% confi-
dence intervals using paired sample analysis for comparisonperiod of CRRT.
between identical time points for dialysis against the two
Patient characteristics different solutions. Nonparametric variables (inotrope
requirements in different subgroupings) were analyzedAll patients had multi-organ system failure with (at
least) acute renal and respiratory failure caused by a by chi-squared testing. All statistical analysis was per-
formed using “Minitab 10 for Windows.”wide range of clinical problems (Table 3). Patients were
not randomized or stratified in terms of whether they
received lactate-buffered or lactate-free dialysate first,
RESULTS
and patients with liver dysfunction (as defined by ele-
Systemic acidosisvated liver enzymes or bilirubin or impaired liver syn-
thetic function) were more likely to receive lactate-free The correction of systemic acidosis was significantly
greater in the time periods when patients were on thedialysate as their initial modality. Patients who had lac-
tate-buffered dialysate first and then lactate-free dialy- lactate-free dialysate than during CRRT with the lactate-
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Table 3. Patient and group characteristics
First dialysate solution used
Lactate-buffered Lactate-free Total
Number of patients 26 28 54
Diagnostic groups
Acetaminophen overdose 2 3 5
Post-liver transplantation 2 6 8
Decompensated cirrhosis 3 1 4
Acute hepatitis 0 2 2
Patients with liver dysfunction (total) 7 12 19
Post-surgical 4 8 12
Non-surgical sepsis 5 2 7
CRF/renal transplantation 4 2 6
Hematological malignancy/BMT 3 1 4
Cardiogenic shock post-MI 2 0 2
Scleroderma hypertensive crisis 1 1 2
Multisystem small vessel vasculitis 0 2 2
Parameters prior to starting CRRT Mean (95% CI)
Age 49.9 (43.4–56.4) 46.1 (40.3–51.8) 47.4 (41.1–53.5)
Apache II score on admission to ICU 20.0 (17.2–22.8) 21.9 (18.8–25.0) 21.0 (18.9–23.1)
Worst Apache II score in first 24 h 25.8 (22.5–29.2) 28.7 (25.5–31.9) 27.3 (25.0–29.6)
[H1] nmol/L 51.1 (48.2–53.9) 52.5 (48.5–56.5) 51.7 (49.4–54.2)
pCO2 kPa 5.3 (4.93–5.69) 5.05 (4.73–5.38) 5.18 (4.93–5.43)
pO2 kPa 12.6 (11.1–14.2) 14.5 (13.1–15.9) 13.2 (12.5–14.65)
[HCO23 ] mmol/L 19.45 (18.3–20.5) 18.6 (16.9–20.2) 19.0 (18.0–20.0)
[Na1] mmol/L 135.7 (133.2–138.1) 138.2 (136.0–140.4) 137.0 (135.3–138.6)
[Lactate]a mmol/L 1.31 (1.02–1.60) 2.31 (1.77–2.86) 1.80 (1.46–2.13)
MAP mm Hg 78.8 (73.2–84.3) 76.6 (73.6–79.8) 77.6 (74.6–80.7)
Clinical and physiological characteristics of patients involved in study by the type of dialysate used in the first 24 hours of CRRT.
a P 5 0.02; other physiological parameters were not significantly different between the two groups
buffered solution (Fig. 1A). Prior to the initiation of to 5.09, P , 0.01), the rise in Na1 during dialysis against
the lactate-free solution was not significant (mean 136.8each type of CRRT, there was no significant difference
vs. 138.3 mmol/L, 95% CI for change in Na1 duringin [H1] (lactate-free vs. lactate-buffered [H1] mean: 52.9
CRRT against lactate-free solution 20.8 to 3.9 mmol/L,nmol vs. 51.6 mmol, 95% CI for difference of means
P 5 0.2). The difference in correction of acidosis was22.1 to 4.7 nmol, equivalent to mean pH of 7.28 vs.
evident in patients with and without liver dysfunction7.29). At the end of 24-hour CRRT, mean [H1] had
(Table 4) and was reflected in a rise in arterial bicarbon-normalized during dialysis against lactate-free dialysate
ate during dialysis against lactate-free dialysate (Fig. 2B).to 41.09 versus 50.68 nmol after exposure to lactate-
buffered dialysate (95% CI for difference between the
Blood buffer administration/replacementmeans 7.36 to 11.81 nmol, P , 0.01, equivalent to mean
pH of 7.39 vs. 7.30). This difference was evident across Calculation of the total buffer administered to patients
during exposure to the different dialysates showed thatthe range of different degrees of acidosis in these pa-
tients, with a convergence of [H1] during CRRT with the difference in correction of acidosis between lactate-
free and lactate-buffered systems was not due to a greaterlactate-free dialysate over the first 12 to 18 hours so that
by 18 hours into CRRT, patients with severe and moderate level of buffer replacement during lactate-free CRRT.
In fact, buffer administration was less during the lactate-acidosis at the commencement of CRRT had lower mean
[H1] than patients starting CRRT against lactate-buffered free period than during lactate-buffered CRRT (Fig. 3),
although it should be noted that buffer replacement wasdialysate with mild or no acidosis (Fig. 1B).
There was no significant disturbance of arterial blood used exclusively with bicarbonate during the lactate-free
period, and predominantly with sodium-lactate duringgasses during CRRT with either dialysate (Fig. 2A).
Blood sodium concentration rose during the period of lactate-buffered CRRT.
CRRT against the lactate-free dialysate and fell slightly
Lactate accumulationduring exposure to lactate-buffered solution (Fig. 2A).
Although the Na1 at the end of 24-hour lactate-free Blood L-lactate levels rose during CRRT against lac-
CRRT was significantly higher than at the end of the tate-buffered dialysate and fell during exposure to the
period with lactate-buffered solution (mean 138.3 vs. 135.1 lactate-free system (Fig. 2B). The difference between the
lactates before and after 24 hours of lactate-free dialysismmol/L, 95% CI for difference between the means, 1.35
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Fig. 1. Control of acidosis with lactate-free (HCO23 replacement) and
lactate-buffered dialysate. (A) Mean and SEM arterial hydrogen ion
concentration during the first 24 hours of CRRT against lactate-free
(j) and lactate-buffered (h) dialysate. (B ) Mean and SEM arterial
hydrogen ion concentration during the first 24 hours of CRRT against
lactate-free and lactate-buffered dialysate in patients with severe acido-
sis (pH , 7.25, [H1] .56 nmol), moderate acidosis (pH 7.25 to 7.3,
[H1] 50 to 56 nmol), and mild acidosis (pH . 7.3, [H1] , 50 nmol).
Symbols are: (d) severe, (j) moderate, (m) mild lactate-free dialysate;
(s) severe, (h) moderate, (n) mild lactate-buffered dialysate.
Fig. 2. Changes in blood gas, sodium, buffer, and blood pressure levels
with lactate-free (HCO23 replacement) and lactate-buffered dialysate.
(A) Blood sodium and arterial blood gas concentration during the first
24 hours of CRRT against lactate-free (j) and lactate-buffered (h)achieved statistical significance (mean lactate at time 0 vs.
dialysate. (B ) Arterial bicarbonate and L-lactate concentration duringmean lactate after 24 hours of lactate-free dialysate 2.27
the first 24 hours of CRRT against lactate-free (d, j) and lactate-
vs. 1.7 mmol/L, 95% CI for the fall in lactate 0.15 to 1.3 buffered (s, h) dialysate. (C ) MAP during the first 24 hours of CRRT
against lactate-free (j) and lactate-buffered (h) dialysate. Data aremmol). The rise in lactate during CRRT with lactate-
mean and SEM.buffered solution was also significant (mean lactate at
time 0 vs. mean lactate after 24-hour lactate-buffered
dialysate 1.41 vs. 2.19 mmol/L, 95% CI for the rise in
lactate 0.18 to 1.37 mmol). There was no significant dif-
rose during the lactate-free dialysate period (Fig. 2C).
ference in lactate accumulation between those patients
The change in MAP was significantly different during thewith acute liver dysfunction and those without, either
lactate-free period compared with the lactate-bufferedwhen comparing the response to the two different dialy-
period. The mean fall in MAP during lactate-bufferedsate systems or considering the combined lactate changes
CRRT was 2.66 mm Hg, and the mean rise in MAPover the two periods of CRRT (Table 4).
during lactate-free CRRT was 5.76 mm Hg (95% CI for
Blood pressure and inotrope requirements difference in MAP between lactate-buffered and lactate-
free periods 0.2 to 16.0 mm Hg, P 5 0.03).There was no significant difference between the blood
During CRRT with lactate-buffered dialysate, sevenpressures at the beginning of the 24-hour period of CRRT
patients had a decrease in inotrope requirement, andagainst lactate versus lactate-free dialysate. MAP fell
slightly during CRRT with lactate-buffered dialysate and nine had increased requirements. During the lactate-free
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Table 4. Comparison of patients with and without liver dysfunction
Patients with liver dysfunction Patients without liver dysfunction
Lactate-buffered Lactate-free Lactate-buffered Lactate-free
[H1] nmol/L 22.3 (24.4 to 20.2) 29.3 (213.1 to 25.6) 20.02 (22.5 to 2.5) 213.4 (216.2 to 210.6)
[Lactate] mmol/L 0.7 (0.4 to 0.9) 20.1 (20.6 to 0.4) 0.8 (0.1 to 1.6) 20.7 (21.1 to 20.3)
[HCO3–] mmol/L 20.3 (21.5 to 1.0) 3.5 (1.4 to 5.5) 20.8 (21.9 to 0.3) 5.6 (4.1 to 7.2)
[Na1] mmol/L 21.5 (23.9 to 1.0) 1.3 (20.5 to 3.2) 20.7 (22.7 to 1.4) 1.6 (0.3 to 3.1)
MAP mm Hg 3.1 (24.7 to 10.1) 0.8 (26.3 to 8.0) 27.4 (212.6 to 22.2) 8.6 (3.3 to 13.9)
Comparison of changes over 24 hours CRRT in acidosis, lactate, bicarbonate, sodium, and blood pressure between patients with, and those without liver dysfunction.
Data are means (95% CI)
sate was mostly evident in patients receiving this treat-
ment second (1.31 vs. 0.36 mmol/L in patients exposed
to lactate-buffered solution as the first treatment).
Changes in MAP over the 24-hour period showed some
differences depending on the order of treatment with
a greater rise in MAP during exposure to lactate-free
dialysate occurring when this was the first treatment (7.75
vs. 3.7 mm Hg when it was the second treatment). The fall
in MAP observed during CRRT against lactate-buffered
dialysate was confined to those patients for whom this
was the second treatment (5.31 mm Hg vs. a rise of 0.2
mm Hg in patients dialyzed against this solution first).
Patients who died before completing 24-hour CRRT
against both dialysates
Seven patients were exposed to both dialysate solu-
tions but died before completing 24-hour CRRT against
Fig. 3. Correction of acidosis and total buffer administration with lac- the second solution. Four of these received lactate-free
tate-free (HCO23 replacement) and lactate-buffered dialysate. Data are dialysate first, and three received the lactate-bufferedmean and SEM of the extent of correction of acidosis (change in hydro-
gen ion concentration in nmol) over the first 24 hours of CRRT against solution. As a group, they had higher Apache II scores
lactate-free and lactate-buffered dialysate against the total buffer deliv- than the patients who completed the protocol (Table 5).
ered by the CRRT circuit plus supplementary HCO23 administration. Analysis of their data censored beyond the time of death
showed that as with the patients in the main analysis,
correction of systemic acidosis was better during lactate-
free CRRT with less total buffer administration. Unlikeperiod, 20 patients had reduced inotrope usage, and 6
the patients who completed 24 hours against both solu-had increased requirements (x2 5 8.37, P 5 0.015).
tions, this group showed no improvement in blood lactate
Effects of order of treatment levels during lactate-free CRRT, and there was no differ-
The order of treatment (lactate-free or lactate-buf- ence in blood pressure response between the periods of
fered dialysate as the initial mode of CRRT) had no exposure to the different dialysates.
effect on the degree of change in systemic acid-base
status brought about by the different dialysates. (The
DISCUSSIONmean fall in [H1] during CRRT against lactate-free solu-
Lactate-buffered dialysis or substitution fluids havetion in patients for whom this was the first treatment vs.
been in use for CRRT for more than 20 years [1], andthose for whom it was the second was 12.2 vs. 12.6 nmol,
their effectiveness, in terms of providing buffer replace-and the mean fall in [H1] during CRRT against lactate-
ment, is well established. However, several aspects ofbuffered solution in patients for whom this was the first
their use remain poorly understood. In particular, thetreatment vs. those for whom it was the second was 20.1
widely quoted rubric that lactate is “metabolized to bi-vs. 1.9.) The fall in blood lactate levels during CRRT
carbonate” represents a simplification. In fact, lactateagainst lactate-free dialysate was also unaffected by the
must be converted to pyruvate with subsequent comple-order of treatment (0.66 vs. 0.71 mmol/L in patients re-
tion of the oxidative cycle, or gluconeogenesis must beceiving this treatment first vs. second). The small rise in
blood lactate during exposure to lactate-buffered dialy- completed from two lactate molecules for the titration
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Table 5. Patients who died before completing 24 hours of CRRT against both dialysate solutions
Age 45.7 (35.3–56.1)
Apache II score on admission to ICU 24.6 (18.5–30.9)
Worst Apache II score in first 24 hr 36.3 (31.3–41.4)
Lactate-buffered dialysate Lactate-free dialysate
Time 0 hour Time 24 hours Time 0 hour Time 24 hours
[H1] nmol/L 57.9 (35.8–79.9) 49.5 (31.5–67.6) 59.8 (48.3–71.5) 43.0 (40.9–45.1)
pCO2 kPa 6.15 (4.92–7.38) 4.59 (4.23–4.96) 4.84 (4.3–5.38) 5.45 (4.85–6.05)
pO2 kPa 13.8 (9.7–17.9) 10.4 (8.6–12.2) 12.53 (9.73–15.33) 18.13 (8.30–27.95)
[HCO23 ] mmol/L 21.1 (16.9–25.4) 19.5 (15.3–23.9) 16.0 (12.8–19.2) 23.9 (20.7–27.1)
[Na1] mmol/L 134 (127–141) 136 (134–137) 131 (127–135) 136 (129–144)
[Lactate] mmol/L 2.66 (0.67–4.65) 5.50 (2.35–8.66) 5.12 (3.20–7.04) 5.17 (1.67–8.66)
MAP mm Hg 67.1 (56.9–77.3) 77.8 (66.7–88.4) 67.9 (53.6–82.1) 75.4 (71.3–79.5)
Total base administered mmol 2388 (1499–3277) 1032 (727–1337)
Changes in acid-base status, gas exchange, serum sodium, venous lactate levels, and blood pressure in 7 patients who were exposed to both dialysate solutions,
but died before completing 24 hours CRRT against the second solution. Four patients died while on lactate-buffered CRRT and three while on the lactate-free
system.
of protons (one or two, respectively) to occur. The supe- rise in blood lactate levels compared with the systems
used in previous reports. The systems that deliver largerriority of HCO23 to acetate-buffered solutions in inter-
mittent dialysis [5] has led to a range of systems designed lactate loads have been shown to produce similar degrees
of correction of acidosis to bicarbonate-buffered systemsto provide continuous, HCO23 -buffered renal replace-
ment. This poses technical difficulties because of the [7, 9, 10], although all of these involved a comparison
with bicarbonate-buffered circuits that delivered lesstendency of HCO23 in solution to form precipitates with
calcium or magnesium ions, and the ability of CO2 buffer (as HCO23 on a molar basis) than the lactate-
buffered circuits. With a system providing less lactate(formed by the dissociation of bicarbonate) to diffuse
through commonly used flexible plastics. These can be influx, we found that the bicarbonate-based system pro-
duced a significantly better reduction in [H1] concentra-overcome by either delaying the admixture of HCO23 to
the solutions until shortly before their use [6–10] or, as tions than the lactate-buffered fluid, despite a smaller
net provision of buffer or buffer substrate. It is unclearin the system we have developed, using a buffer-free
dialysate and giving the buffer replacement separately. what was happening to the lactate that our patients re-
ceived from the dialysate and successfully cleared fromPrevious reports comparing between lactate and bicar-
bonate-buffered systems reveal clear quantitative effects their blood compartment, because evidently it was not
being “metabolized to bicarbonate in the liver.”in relationship to both lactate accumulation and acid-
base control. Systems of intermittent hemofiltration in The rise in blood lactate produced by lactate-buffered
dialysis or filtration fluids may [11] or may not [9, 13]which large volumes of lactate-buffered replacement
fluid are administered over relatively short periods of be associated with hemodynamic instability. The ques-
tion of whether such hyperlactemia is harmful in itselftime produce the largest rises in blood lactate [11], con-
tinuous circuits using solutions with 44.5 mmol lactate is complex. This is due to the fact that a rise in lactate
after the challenge of lactate infusion from the CRRTproducing a rise in lactate from a mean of about 2
mmol/L to over 4 mmol/L at 24 hours in one report [9] circuit will not only be a marker of poor regional perfu-
sion and hepatic function, but also of the failure of theand levels twice those seen in patients on bicarbonate-
buffered CRRT at four days in another [7]. It should be CRRT system to replace the buffer that is being re-
moved. Whether the well-established mild hyperlac-noted that the observed rise in L-lactate after exposure
to lactate-buffered dialysate in these and in our study is temia of lactate-buffered CRRT is a cause of hemody-
namic instability or merely its correlate, our patientsvery small relative to the net influx of lactate from the
CRRT circuit. Given the efficiency of equilibration of demonstrated a clear improvement in inotrope require-
ments as a group during bicarbonate-buffered CRRT,lactate across the filters, this would be approximately
1000 to 1500 mmol of total lactate during a 24-hour which did not occur during their lactate-buffered period.
Our data are retrospective, and patients were not ran-period. The vast majority of the delivered lactate is evi-
dently being cleared from the blood because of the small domized with respect to their initial treatment. Thus,
consideration must be given to potential biases that mayrises in blood lactate seen relative to the amount of
lactate delivered and its volume of distribution [12]. have arisen in our patient group. The most significant
of these is the tendency for patients with liver diseaseThe lactate-buffered system that we used delivers rela-
tively less lactate and produces a concomitantly smaller and higher lactates to receive lactate-free dialysate first.
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